All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

259

Reset

259 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • NWRD09Phase 22 trials

    Newish Biotech (Wuxi) Co., Ltd. · High-grade Squamous Intraepithelial Lesion (HSIL), Persistent HPV16 Infection

  • Seqker Biosciences, Inc. · Solid Tumors, Advanced Cancer, Recurrent Cancer

  • RBD1016Phase 22 trials

    Ribocure Pharmaceuticals AB · Chronic Hepatitis D, Chronic Hepatitis b

  • rC19Novavax's adjuvanted recombinant COVID-19Phase 22 trials

    Sanofi · COVID-19 Immunization, Influenza Immunization

  • rhu-pGSNrecombinant human gelsolin, Recombinant human plasma gelsolin pre-exposurePhase 22 trials

    BioAegis Therapeutics Inc. · Acute Respiratory Distress Syndrome, Infections, Decompression Sickness

  • RSV vaccine candidatePhase 22 trials

    Sanofi · Respiratory Syncytial Virus Infection, Healthy Volunteers, Respiratory Syncytial Virus Immunization

  • STAR0602InvikafuspPhase 22 trials

    Marengo Therapeutics, Inc. · Triple Negative Locally Advanced Non-resectable Breast Cancer, HR+, HER2-, Advanced Breast Cancer, Advanced Solid Tumors

  • TNP-2092rifaquizinonePhase 22 trials

    TenNor Therapeutics (Zhongshan) Limited · Prosthetic Joint Infection (PJI), Periprosthetic Joint Infection (PJI)

  • TRX-100Phase 22 trials

    Traws Pharma, Inc. · Influenza

  • AB-729Phase 21 trial

    Arbutus Biopharma Corporation · Chronic Hepatitis b

  • ABI-2280Phase 21 trial

    Antiva Biosciences · Human Papillomavirus Infection

  • ABI-6250Phase 21 trial

    Assembly Biosciences · Chronic Hepatitis D Infection

  • ABO1105Phase 21 trial

    Suzhou Abogen Biosciences Co., Ltd. · Respiratory Syncytial Virus

  • ADX-629Phase 21 trial

    Aldeyra Therapeutics, Inc. · Alcohol Hepatitis

  • AFX3772Phase 21 trial

    GSK · Pneumonia, Bacterial, Pneumococcal Infections, Pneumonia, Pneumococcal

  • AHB-171Phase 21 trial

    Ausper Biopharma Co., Ltd. · Hepatitis B, Chronic (CHB)

  • AIC263029Phase 21 trial

    AiCuris Anti-infective Cures AG · BK Virus Infection, BKV Infection, Kidney Transplant

  • ALG-000184Phase 21 trial

    Aligos Therapeutics · Chronic Hepatitis B Infection

  • Alpe375Phase 21 trial

    BioVersys AG · Tuberculosis Meningitis

  • AlpE500Phase 21 trial

    BioVersys AG · Tuberculosis Meningitis

  • AlpE625Phase 21 trial

    BioVersys AG · Tuberculosis Meningitis

  • ApomivirFE-L-APO, drug substancePhase 21 trial

    Far East Bio-Tec Co., Ltd · Influenza

  • ARCT-2304Phase 21 trial

    Arcturus Therapeutics, Inc. · Influenza, Human

  • ASK0912Phase 21 trial

    Jiangsu Aosaikang Pharmaceutical Co., Ltd. · Ventilator-associated Bacterial Pneumonia (VABP), Hospital-acquired Bacterial Pneumonia (HABP)

  • AV-001Phase 21 trial

    Vasomune Therapeutics, Inc. · Acute Respiratory Distress Syndrome, Viral or Bacterial Infections, Pneumonia

  • AZD2693Phase 21 trial

    AstraZeneca · Nonalcoholic Steatohepatitis

  • AZD4117Phase 21 trial

    AstraZeneca · Influenza A

  • AZD5148Phase 21 trial

    AstraZeneca · Clostridioides Difficile Infection

  • AZD5315Phase 21 trial

    AstraZeneca · Influenza A

  • AZD6489Phase 21 trial

    AstraZeneca · RSV Respiratory Syncytial Virus

  • BemnifosbuvirAT-527Phase 21 trial

    Atea Pharmaceuticals, Inc. · Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C

  • BI 770371Phase 21 trial

    Boehringer Ingelheim · Compensated Liver Cirrhosis, Metabolic Dysfunction Associated Steatohepatitis (MASH)

  • BLB-201PIV5-vectored RSV VaccinePhase 21 trial

    Blue Lake Biotechnology Inc. · Respiratory Syncytial Virus Infections

  • BNT164a1Phase 21 trial

    BioNTech SE · Tuberculosis

  • BNT164b1Phase 21 trial

    BioNTech SE · Tuberculosis

  • BNT165cPhase 21 trial

    BioNTech SE · Malaria

  • BNT165dPhase 21 trial

    BioNTech SE · Malaria

  • BTZ-043Phase 21 trial

    GSK · Tuberculosis

  • BX004Combination of nebulized bacteriophages targeting Pseudomonas aeruginosaPhase 21 trial

    BiomX Ltd · Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis (CF)

  • CAL02Phase 21 trial

    Eagle Pharmaceuticals, Inc. · Pneumonia, Bacterial

  • CAP256V2LSPhase 21 trial

    Gilead Sciences · HIV-1-infection

  • CL-197Phase 21 trial

    Henan Genuine Biotech Co., Ltd. · HIV-1 Infection

  • CMTX-101Phase 21 trial

    Clarametyx Biosciences, Inc. · Persistent Infection, Cystic Fibrosis

  • DaplusiranTomligisiranPhase 21 trial

    GSK · Chronic Hepatitis B Virus Infection, Hepatitis B

  • Dispensing CodivirPhase 21 trial

    Code Pharma · HIV, HIV Infection

  • DL001ZF2G22B, F2H23HPhase 21 trial

    GSK · Influenza, Human

  • DL001Z-NHF2H23D, F2H23BPhase 21 trial

    GSK · Influenza, Human

  • ECC0509Phase 21 trial

    Eccogene · Metabolic Dysfunction-associated Steatohepatitis

  • EDP-938Phase 21 trial

    Enanta Pharmaceuticals, Inc · RSV Infection

  • EfesovirFS-1Phase 21 trial

    Scientific Center for Anti-infectious Drugs, Kazakhstan · Covid19

NewerPage 4 of 6Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.